发明授权
- 专利标题: System and method for the objective evaluation of sympathetic nerve dysfunction
-
申请号: US15842091申请日: 2017-12-14
-
公开(公告)号: US11089996B2公开(公告)日: 2021-08-17
- 发明人: David Michael Sitton , Christopher P. Dougherty , Samuel F. Arndt, III
- 申请人: Episcan Global, LLC
- 申请人地址: US OK Tulsa
- 专利权人: Episcan Global, LLC
- 当前专利权人: Episcan Global, LLC
- 当前专利权人地址: US OK Tulsa
- 代理机构: Smith Patent, LLC
- 代理商 Chalin A. Smith
- 主分类号: A61B5/00
- IPC分类号: A61B5/00 ; A61B5/053 ; G16H15/00 ; G16H10/60 ; G16H10/40 ; G16H50/70 ; G16H20/40 ; G16H20/10 ; G16H20/30 ; A61B5/01 ; A61B5/145 ; A61B8/08 ; A61B5/1455
摘要:
Various methods and machines have been used in the past to measure electrical characteristics of living tissue for purpose of locating an area of abnormal nervous system activity. However, whereas prior art methodologies merely allow for the detection of pain, the apparatus, system and method of the present invention allow for the objective assessment pain severity that finds utility not only the initial diagnosis but also the on-going treatment of any disease, disorder or injury associated therewith. To that end, the apparatus, system and method of the present invention allows medical practitioners to non-invasively and quantitatively distinguish organic pain from psychosomatic pain and legitimate pain patients from drug seekers and opiod addicts, as well as to directly and objectively compare the efficacy of different drug regimens and therapy protocols.
公开/授权文献
信息查询